What should I Know Regarding Pregnancy, Nursing and Administering Nasal Decongestant PD Capsule, Extended Release to Children or the Elderly?

If you are PREGNANT

  • Only When Necessary: FDA C W/COMBO PROD; POSS RISK OF GASTROSCHISIS/SIA WITH 1ST TRIMESTER EXPOSURE
  • Only When Necessary: BROMPHENIRAMINE TANNATE FDA CATEGORY C, BROMPHENIRAMINE MALEATE CATEGORY B.

If you are NURSING

  • Precaution: MAY DECREASE MILK SUPPLY, AND CAUSE IRRITABILITY
  • Precaution: NOT RECOMMENDED. MAY CAUSE PARADOXICAL EXCITATION/INHIBIT LACTATION.

If you are an adult over 60

  • management or monitoring precaution: Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
  • management or monitoring precaution: Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Non-sedating agents preferred. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.

Giving Nasal Decongestant PD Capsule, Extended Release to a child under 12

  • Contraindication: Increased sensitivity to side effects. Dose form or strength not appropriate.
  • Contraindication: Do not use in pediatrics <12 years of age unless clinician consultation.
  • Contraindication: Possible CNS excitation, convulsions in newborns.